메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한내과학회 대한내과학회지 대한내과학회지 제77권 제2호
발행연도
2009.1
수록면
157 - 164 (8page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Since the first case with swine origin influenza A (H1N1) infection has been described in Mexico and the United States in April 2009, novel influenza A (H1N1) virus has been spread to all over the world. WHO has officially declared the outbreak to be an influenza pandemic by 11 June. The number of human cases and death of pandemic A (H1N1) 2009 is still increasing substantially in many countries with widespread community transmission. The natural course of novel influenza A (H1N1) still appears to be generally mild and mostly recovered. It predominantly affects children and young adults with relative sparing of older age groups, supporting a theory that older people have some cross-reactive antibodies to novel influenza A (H1N1) from previous infection or immunization. People with chronic medical conditions and pregnancy are more likely to be hospitalized with or dead from the novel influenza A (H1N1). Antiviral treatment by using neuraminidase inhibitors (oseltamivir, zanamivir) is recommended mainly for all hospitalized patients with novel influenza (H1N1) and patients who are at higher risk for seasonal influenza complications. Continued pandemic preparedness, flexible response and careful monitoring are essential because influenza viruses are unpredictable. This article reviews the current epidemiology, clinical manifestations, and management of pandemic novel influenza A (H1N1).

목차

등록된 정보가 없습니다.

참고문헌 (27)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0